STING1 and neoplasm: The stimulator of IFN genes (STING) pathway is an essential component in the activation of antigen-presenting cells (APCs), resulting in enhanced production of type I IFN and proinflammatory cytokines that induce the differentiation of tumor-specific CD8+ T lymphocytes19.